BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27703114)

  • 1. Sex and Gender Differences in Gastroesophageal Reflux Disease.
    Kim YS; Kim N; Kim GH
    J Neurogastroenterol Motil; 2016 Oct; 22(4):575-588. PubMed ID: 27703114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
    Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
    Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haplotypes of the IL-1 gene cluster are associated with gastroesophageal reflux disease and Barrett's esophagus.
    Izakovicova Holla L; Borilova Linhartova P; Hrdlickova B; Marek F; Dolina J; Rihak V; Kala Z
    Hum Immunol; 2013 Sep; 74(9):1161-9. PubMed ID: 23806268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.
    Voutilainen M; Sipponen P; Mecklin JP; Juhola M; Färkkilä M
    Digestion; 2000; 61(1):6-13. PubMed ID: 10671769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of luminal nitric oxide in the pathogenesis of the gastroesophageal reflux disease spectrum.
    Iijima K; Shimosegawa T
    J Gastroenterol Hepatol; 2014 May; 29(5):898-905. PubMed ID: 24863184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the real impairment on esophageal motility in patients with gastroesophageal reflux disease?
    Falcão A; Nasi A; Brandão J; Sallum R; Cecconello I
    Arq Gastroenterol; 2013 Apr; 50(2):111-6. PubMed ID: 23903620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities.
    Martínek J; Benes M; Hucl T; Drastich P; Stirand P; Spicák J
    Scand J Gastroenterol; 2008; 43(7):794-800. PubMed ID: 18584517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups.
    Dickman R; Bautista JM; Wong WM; Bhatt R; Beeler JN; Malagon I; Risner-Adler S; Lam KF; Fass R
    Am J Gastroenterol; 2006 Nov; 101(11):2463-9. PubMed ID: 17090277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reflux disease and Barrett's oesophagus - are there gender-specific differences?].
    Endlicher E; Gelbmann CM; Messmann H
    Z Gastroenterol; 2009 Oct; 47(10):1065-8. PubMed ID: 19809958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.
    Csendes A; Smok G; Cerda G; Burdiles P; Mazza D; Csendes P
    Dis Esophagus; 1997 Jan; 10(1):38-42. PubMed ID: 9079272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
    Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
    Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonerosive reflux disease.
    Long JD; Orlando RC
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):127-41. PubMed ID: 17557041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of environment and lifestyle on gastroesophageal reflux disease.
    Sonnenberg A
    Dig Dis; 2011; 29(2):229-34. PubMed ID: 21734389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of correlation between gastroesophageal reflux disease symptoms and esophageal lesions after sleeve gastrectomy.
    Soricelli E; Casella G; Baglio G; Maselli R; Ernesti I; Genco A
    Surg Obes Relat Dis; 2018 Jun; 14(6):751-756. PubMed ID: 29571635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Anderson LA; Cantwell MM; Watson RG; Johnston BT; Murphy SJ; Ferguson HR; McGuigan J; Comber H; Reynolds JV; Murray LJ
    Gastroenterology; 2009 Mar; 136(3):799-805. PubMed ID: 19162028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroesophageal reflux disease: presentation and assessment of a common, challenging disorder.
    Soll AH; Fass R
    Clin Cornerstone; 2003; 5(4):2-14; discussion 14-7. PubMed ID: 15101491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology and management of gastroesophageal reflux disease.
    Rohof WO; Hirsch DP; Boeckxstaens GE
    Minerva Gastroenterol Dietol; 2009 Sep; 55(3):289-300. PubMed ID: 19829285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.